The size of the Protein Expression Market in Middle-East Africa was worth USD 145.64 million in 2022. It is estimated to be growing at a CAGR of 4.025% and worth USD 177.40 million by 2027.
The MEA protein expression market is expected to be driven by the proliferation of chronic diseases such as diabetes, cancer, and multiple sclerosis. In addition, the availability of various commercial cell-free expression systems boosts market growth. The growing application of protein expression and the technological advancements and adoption of innovations in protein expression support the market expansion. The shorter-expression time and structural modification are the other factors driving the market growth. Other factors such as the growing geriatric population and the increasing awareness among the people influence the demand for protein expression across the region.
Major players in the market and the government are significantly investing the research and infrastructure development which is expected to provide lucrative growth opportunities for the market players. Moreover, the recent pandemic covid-19 has been increased the need for large-scale production of therapeutic proteins for the treatment of the disease. As a result, pharmaceutical and biopharmaceutical companies develop various protein expression hosts and bioprocessing technologies that support market growth.
Furthermore, the key market players implementing various market strategies such as collaborations, mergers, and acquisitions are more likely to expand and strengthen the regional market growth.
However, the lack of skilled professionals and the stringent government regulations on protein expression limit market growth. Also, the high cost of products hinders market growth.
This research report on the Middle East and Africa Protein Expression Market has been segmented and sub-segmented into the following categories:
By Expression Systems:
By End User:
The MEA is estimated to account for a moderate share in the protein expression market during the forecast period. The regional market growth is attributed to the improving healthcare infrastructure, a significant increase in the evolution of pharmaceutical and biopharmaceutical industries in the region, and favorable government policies. As a result, the countries such as South Africa, UAE, and Saudi Arabia contribute to the majority share of the market in the region.
South Africa accounted for the largest share of the market in 2020, and it is anticipated to continue its growth during the forecast period. An increase in the use of protein technology, rising research and development activities, and high healthcare expenditure are fuelling the market growth.
Furthermore, other countries such as UAE and Saudi Arabia are projected to register a considerable share in the market over the forecast period. The market growth is contributed owing to the factors such as the increasing prevalence of chronic diseases, advancing healthcare infrastructure, and the presence of key market players.
Saudi Arabia's kingdom is important to the country's economic progress. However, the country is mostly concerned about producing industrial items and exports to other parts of the world. Furthermore, government measures to strengthen healthcare infrastructure, increased investments, and non-profit support for protein expression research and development activities are paving the way for new market entrants.
KEY MARKET PLAYERS:
Companies playing an influential role in the MEA protein expression market profiled in the report are Agilent Technologies, Life Technologies Corporation, Bio-Rad Laboratories, New England BioLabs, Merck Millipore, Takara Bio, Thermo Fisher Scientific, and Promega Corporation.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org